The Shirley Ryan AbilityLab will execute clinical research studies using MC10’s BioStampRC® product, a wearable sensor system designed to seamlessly capture physiological data from across the body.

“MC10’s technology has the potential to reshape rehabilitation. We look forward to developing new therapies and solutions with BioStampRC sensors, furthering our goal of improving treatment and recovery, and of advancing human ability,” stated David Zembower, Ph.D., Executive Director of Innovation and Clinical Research at the Shirley Ryan AbilityLab.

“MC10 is dedicated to improving healthcare with digital solutions. By collaborating with the Shirley Ryan AbilityLab, an institution committed to driving breakthroughs in human ability, we’re positioning our technology to make a real, positive impact in human health,” commented Scott Pomerantz, Chief Executive Officer of MC10. The Shirley Ryan AbilityLab and MC10 plan for multiple publications and conference proceedings to share outcomes from their clinical study collaboration.

About MC10, Inc. MC10 is a private company, backed by a strong syndicate of financial and strategic investors, that is improving human health through digital healthcare solutions.

MC10 has received widespread recognition for its revolutionary technology and was recently named in Fast Company’s Most Innovative Companies in 2016 as a leader in healthcare.

MC10 is headquartered in Lexington, MA. Visit MC10 online at www.

MC10®, BioStampRC® and the MC10 logo are registered marks owned by MC10, Inc..